logo

For the Inventor, By the Inventor

Stockholm, Sweden

Arexis Ab


USPTO Granted Patents = 14

% Expired Patents = 71.4



Trademarks = 3

Forward Citations = 25

Loading Chart...
Loading Chart...

38 inventors (with patents filed for the assignee):

goldMedal Leif Andersson (3 out of 16 patents)

silverMedal Rikard Holmdahl (3 out of 11 patents)

bronzeMedal Erica Shane (2 out of 15 patents)

4.  Cynthia N Oliver (2 out of 12 patents)

5.  Benjamin S Isaacs (2 out of 15 patents)

6.  Christian B Allan (2 out of 19 patents)

7.  Stephen T Chang (2 out of 12 patents)

8.  Göran Hjälm (2 out of 4 patents)

9.  Peter Olofsson (2 out of 2 patents)

10.  Stefan Marklund (2 out of 4 patents)

11.  Sureshkumar Choudhary (1 out of 1 patent)

12.  Tesfu Mezghebe (1 out of 1 patent)

13.  Mary Houchin (1 out of 1 patent)

14.  Eric Vernooij (1 out of 1 patent)

15.  Marjo Peters (1 out of 1 patent)


14 patents:

1. 11180542 - Stabilized liquid anti-RSV antibody formulations (2021-11-23),
2. 10625180 - Manufacturing method (2020-04-21),
3. 10604560 - Stabilized liquid anti-RSV antibody formulations (2020-03-31),
4. 7943338 - Autoimmune conditions and NADPH oxidase defects (2011-05-17),
5. 7872052 - Use of heterocyclic compounds as SCCE inhibitors (2011-01-18),
6. 7858369 - Expression constructs expressing Prkag3 (2010-12-28),
7. 7476731 - Variants of the alpha 1 subunit of human AMPK (2009-01-13),
8. 7462693 - Variants of the Gamma Chain of AMPX, DNA sequences encoding the same, and uses thereof (2008-12-09),
9. 7452982 - Immunogenic complex (2008-11-18),
10. 7294652 - Autoimmune conditions and NADPH oxidase defects (2007-11-13),
11. 7214850 - Transgenic mouse expressing Prkag3 (2007-05-08),
12. 7208305 - Variants of the α1 subunit of human AMPK (2007-04-24),
13. 7148020 - Triple polypeptide complexes (2006-12-12),
14. 6465714 - Congenic animal models of non-insulin dependent diabetes mellitus (2002-10-15),
Company Overview
Arexis Ab is a biotechnology company based in Stockholm, Sweden, specializing in the development of innovative therapeutics for various diseases. The organization focuses on advancing drug discovery and development processes, particularly in the fields of oncology and autoimmune disorders. Arexis leverages cutting-edge research and technology to create novel solutions that address unmet medical needs, aiming to improve patient outcomes through targeted therapies and precision medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#62 in Stockholm

#454 in Sweden

#42,290 in the World

Stockholm, SE
Stockholm, Sweden

Arexis Ab

Forward Citations = 25

38 inventors:

goldMedal Leif Andersson (3 out of 16 patents)

silverMedal Rikard Holmdahl (3 out of 11 patents)

bronzeMedal Erica Shane (2 out of 15 patents)

4.  Cynthia N Oliver (2 out of 12 patents)

5.  Benjamin S Isaacs (2 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Arexis Ab. Retrieved from https://idiyas.com/company/arexis-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…